FDA Approved: CREON — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved CREON (pancrelipase) under AbbVie’s original Biologics License Application, authorizing its marketing for exocrine pancreatic insufficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• Creon (pancrelipase)

Snippet

ORIG AP for CREON (PANCRELIPASE)